Multiplexed assay technologies at the gene, protein, and cellular levels have enabled the identification of 'actionable biomarkers' that can inform clinical practice. Powerful new methods, including mass cytometry and protein arrays, are reviewed.
- Holden T. Maecker
- Tamsin M. Lindstrom
- C. Garrison Fathman
